2020 CHAIN Center Colloquium (in Collaboration with NIMH Center Series Web Events)

The Chronic HIV and Aging in NeuroAIDS (CHAIN) Center (NIH P30MH062261) in collaboration with the NIMH Center Series Web Events is hosting the 7th Annual CHAIN Center Colloquium. The 2020 colloquium is a virtual event due to the ongoing COVID-19 pandemic. 

The CHAIN Center, an NIMH Centers Program for Research on HIV/AIDS and Mental Health seeks to bring together leaders in the fields to discuss emerging topics, foster new ideas and collaborations, and educate new and established investigators. The talks will be relevant to researchers and clinicians investigating and treating PLWH, with a focus on NeuroHIV. 


Hosts

Chronic HIV and Aging In NeuroAIDS (CHAIN) Center | NIH P30 MH062261

MPI: Drs. Shilpa Buch and Howard Fox

NIMH Center Series Host: Prof. Norman Haughey, PhD


2020 CHAIN Colloquium Speakers

Prof. Scott Letendre, MD
Professor, Department of Medicine, University of California at San Diego

Neurological Complications of COVID-19
Nov 30th, 2020 , 12PM ET (11AM CT/9AM PT)

Scott Letendre, MD, is Professor of Medicine and Psychiatry in Residence in the Division of Infectious Diseases at the University of California, San Diego (UCSD). Dr. Letendre performs translational, patient-oriented research of the central nervous system complications of chronic infections like HIV and CMV. These cohort studies and clinical trials include focused on the pharmacokinetics of antiretrovirals, the neurological effects of comorbidities and polypharmacy, and the biomarker correlates of disease. Dr. Letendre is the recipient of a K24 mentoring award from the National Institute of Mental Health. He is the past Chair of the Neurology Collaborative Science Group of the AIDS Clinical Trials Group and Co-Chair of the International Workshop on HIV & Aging, and is the current Chair of the UCSD Institutional Biosafety Committee. He has participated in international projects in China, India, Romania, Russia, Zambia, and Mozambique. Dr. Letendre balances his research activities with outpatient and inpatient clinical care of persons with HIV and other infectious diseases. He also teaches in the Microbiology course at the UCSD School of Medicine. Dr. Letendre has co-authored over 300 peer-reviewed manuscripts published in journals such as AIDS, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, Journal of Infectious Diseases, Journal of Neurovirology, Journal of Virology, Lancet HIV, and Neurology. 

Prof. Susan Swindells, MBBS 
Professor, Department of Internal Medicine, University of Nebraska Medical Center (UNMC)

Injectable Antiretroviral Therapy: What are the Clinical Data?
Dec 9th, 2020 , 12PM ET (11AM CT/9AM PT)

Susan Swindells is a Professor of Internal Medicine in the Section of Infectious Diseases at the University of Nebraska Medical Center, USA. A native of England, Dr. Swindells earned her medical degree from University College London in 1977, with postgraduate training in England and at the University of Washington in Seattle. She has been involved in HIV care since 1984. A clinician and active researcher, Dr. Swindells has many years’ experience in translational and clinical research in the field of HIV/AIDS, with a special interest in tuberculosis co-infection. She has been the principal investigator on multiple clinical trials and published over 150 original research papers, editorials, and review articles. Dr. Swindells is on the leadership of the AIDS Clinical Trials Group of the National Institutes of Health, and is a member of the U.S. Department of Health & Human Services Panel on Antiretroviral Guidelines. For more than 30 years, she has mentored many students, residents, post-docs and junior faculty. She also devotes her time to capacity building for the international sites that she works with, and in support of community activities. 


Dr. Shelli Farhadian, MD, PhD
Assistant Professor, Department of Neurology, Yale University School of Medicine

Neuropathogenesis during COVID-19 
Dec 14th, 2020 , 12PM ET (11AM CT/9AM PT)

Dr. Shelli Farhadian is Assistant Professor of Medicine (Infectious Diseases) and Neurology at the Yale School of Medicine. Dr. Farhadian received her undergraduate degree from M.I.T. She received her MD from Weill Cornell Medical College and her PhD at The Rockefeller University, where she studied behavioral neuroscience in the laboratory of Dr. Leslie Vosshall. Dr. Farhadian received her medical training at Yale in Internal Medicine, Infectious Diseases, and Neuroinfectious Diseases, and completed an additional T32 research fellowship through the Yale Program on Aging. An early career investigator, Dr. Farhadian is supported by funding from the American Federation for Aging Research and through a NIMH-sponsored K23 career development award, under the mentorship of Dr. Serena Spudich. Dr. Faradian’s current research is dedicated to understanding central nervous system abnormalities in adults with virologically suppressed HIV and other infectious diseases. Her research employs several tools that probe the CNS in living people, including single-cell genomic studies of CSF. Dr. Farhadian serves on the Neurology Collaborative Science Group of the ACTG. She is also a practicing physician and cares for adults with HIV infection.


top of page